Iressa User Fee Date Pushed To May; Will Advisory Cmte. Take Second Look?

 
• By The Pink Sheet

FDA will take regulatory action on AstraZeneca's Iressa (gefitinib) by May 5

More from Archive

More from Pink Sheet